Advanced refractory heart failure: conservative or interventional approach?

Fabio Rigamonti^{1

2}, Fabrizio Montecucco^{2

3

4}, Luca Liberale²

Affiliations

¹ Division of Cardiology, Geneva University Hospital, Geneva, Switzerland.
² First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
³ IRCCS AOU San Martino - IST, Genoa, Italy.
⁴ Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.

Comment

Fabio Rigamonti et al. Eur J Clin Invest. 2017 Feb.

. 2017 Feb;47(2):193-194.

doi: 10.1111/eci.12712. Epub 2016 Dec 29.

Fabio Rigamonti^{1

2}, Fabrizio Montecucco^{2

3

4}, Luca Liberale²

¹ Division of Cardiology, Geneva University Hospital, Geneva, Switzerland.
² First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
³ IRCCS AOU San Martino - IST, Genoa, Italy.
⁴ Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.

No abstract available

Comment on

Outcome of conservative management vs. assist device implantation in patients with advanced refractory heart failure.
Adlbrecht C, Hülsmann M, Wurm R, Eskandary F, Neuhold S, Zuckermann A, Bojic A, Strunk G, Pacher R. Adlbrecht C, et al. Eur J Clin Invest. 2016 Jan;46(1):34-41. doi: 10.1111/eci.12562. Epub 2015 Dec 23. Eur J Clin Invest. 2016. PMID: 26540663